Cannara Biotech (DE:8CB0)
FRANKFURT:8CB0
Holding DE:8CB0?
Track your performance easily

Cannara Biotech (8CB0) Balance Sheet

0 Followers

Cannara Biotech Balance Sheet

Cannara Biotech's total assets for Q3 2024 were C$148.77M, an increase of 2.02% from the previous quarter. DE:8CB0 total liabilities were C$67.00M for the fiscal quarter, a 0.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Aug 23Aug 22Aug 21Aug 20Aug 19
Total Assets
C$ 141.52MC$ 125.62MC$ 92.02MC$ 54.85MC$ 68.10M
Total Liabilities
C$ 61.78MC$ 58.88MC$ 27.91MC$ 16.49MC$ 18.17M
Total Equity Gross Minority
C$ 79.74MC$ 66.74MC$ 64.12MC$ 38.36MC$ 49.93M
Total Capitalization
C$ 119.39MC$ 112.92MC$ 84.27MC$ 50.35MC$ 59.69M
Preferred Stock Equity
-----
Capital Lease Obligations
---C$ 651.76KC$ 697.34K
Currency in CAD

Cannara Biotech Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis